EQRx to trim more than 40 staffers in re­struc­tur­ing ma­neu­ver

Three months af­ter putting on hold its am­bi­tious plan to bring low-cost, in­no­v­a­tive drugs to the US mar­ket, EQRx is shed­ding jobs.

The biotech …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.